hotspot -WSS

hotspot

author：focus 2025-09-30 20:20:13 - browse：9

Two boxes of Humira and a Humira pen on the side — first opinion coverage from STAT — David J. Phillip/AP

It’s been one year since the launch of the first adalimumab biosimilar for Humira in the United States, which was followed by eight additional adalimumab biosimilar launches. These nine FDA-approved products offer lower-cost alternatives to the world’s bestselling drug, Humira, used to treat rheumatoid arthritis, Crohn’s disease, and other autoimmune disorders. This made 2023 a watershed year for millions of U.S. patients paying too much for their necessary medications.

But so far, that vision hasn’t come to fruition, because policymakers haven’t taken the action necessary to be sure these lower-cost products are accessible for patients. If they fail to act, the U.S. health care system could lose up to $133 billion in savings and leave patients without access to the medicines they need.

Biosimilars are safe and effective treatments referencing biologic drugs. They are market disruptors, forcing lower prices for biologic medicines. The cost savings from reference biologic products begins almost immediately when biosimilars enter the market and continues over time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： NIH tests clinical research in primary care with $30 million program

hotspot

WSS

Methadone treatment changes are coming. Do they go far enough?

How faith leaders like me can help address America's obesity epidemic

My daughter's legacy lives on through her writing, phage therapy

5 takeaways from STAT's examination of Zynex Medical

UnitedHealth increases loan offers after Change Healthcare outage

New report analyzes digital physical therapy solutions' effectiveness

leisure time

hotspot

entertainment

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Physicians and social media: If you see something, say something?

Malaria cases in Florida and Texas: Here’s what you need to know

Study: Why relieving medical debt did not improve financial outcomes

BioMarin wins approval for gene therapy to treat hemophilia A

UnitedHealth increases loan offers after Change Healthcare outage

United colonoscopy coverage change 'may cost lives,' doctors say

The system is set up to fail children with medical complexity

Supreme Court strikes down use of affirmative action

CVS Caremark has created a new ploy: the drug ‘rebate credit’

hotspot

Nurses recount patients attacks

Stephen Quake on the Chan Zuckerberg quest to conquer disease

My daughter's legacy lives on through her writing, phage therapy

My daughter's legacy lives on through her writing, phage therapy

Physicians and social media: If you see something, say something?

Methadone treatment changes are coming. Do they go far enough?

focus

hotspot

hotspot

knowledge